Search Results 7251-7260 of 34368 for oral

  1. Tongue cancer - Doctors and departments - Mayo Clinic

    Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating the ...

  2. Tongue cancer - Doctors and departments - Mayo Clinic

    Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating ...

  3. Tongue cancer - Doctors and departments - Mayo Clinic

    Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating ...

  4. Tongue cancer - Doctors and departments - Mayo Clinic

    Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating ...

  5. Tongue cancer - Doctors and departments - Mayo Clinic

    Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating ...

  6. 5-strain Probiotic Formulation in Hormone Receptor-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss - Mayo Clinic

    Patients who received oral bisphosphonate within ≤ 12 weeks, IV zoledronic acid (Reclast) ≤ 52 weeks, or denosumab ≤ 24 weeks will also be excluded.

  7. A Study to Evaluate Yttrium-90 Therapy for Radiation Lobectomy - Mayo Clinic

    Patients with mild claustrophobia are eligible and have the option to take 1mg oral Lorazepam prior to the MRI, if needed;; Allergy to gadolinium-containing ...

  8. A Study of Sporadic Angiomyolipomas Growth Kinetics While on Everolimus - Mayo Clinic

    The purpose of this research study is to see if oral everolimus is a tolerable and effective treatment for sporadic angiomyolipomas tumors of the kidney.

  9. A Study of Using Palbociclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive/ Human Epidermal Growth Factor Receptor 2 Negative Early Breast Cancer - Mayo Clinic

    Must be able and willing to swallow and retain oral medication. Serum or urine pregnancy test must be negative in premenopausal women within 14 days of ...

  10. A Study to Assess the Effectiveness and Safety of Golimumab in Pediatric Participants With Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

    ... oral or intravenous corticosteroids, 6-mercaptopurine, methotrexate or azathioprine OR must either have or have had a history of corticosteroid dependency ...